trial summary · NCT07254793
Prophylactic DLI-X for Leukemia Relapse After HCT
A Feasibility/Pilot First-in-human Study of Exercise-mobilized NK-enriched Donor Lymphocyte Infusions (DLI-X) to Prevent Leukemia Relapse After Allogeneic Hematopoietic Cell Transplantation
Trial record from the TrialBase DB dataset, status RECRUITING, condition Acute Lymphoid Leukemia, sponsored by University of Arizona. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The primary objective of this proposal is to conduct the first-in-human randomized clinical trial evaluating prophylactic DLI-X (pro-DLI-X) for relapse prevention following matched sibling donor (MSD) or haploidentical (haplo) hematopoietic cell transplantation (HCT) in patients with hematologic malignancies. We hypothesize that pro-DLI-X will demonstrate safety and superior efficacy by enhancing graft-versus-leukemia (GvL) effects mediated by natural killer (NK) cells, γδ T cells, and CD8+ T cells, while maintaining manageable and treatment-responsive graft-versus-host disease (GvHD).
Source record: https://clinicaltrials.gov/study/NCT07254793
Facts
| registry id | NCT07254793 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | Acute Lymphoid Leukemia |
| sponsor | University of Arizona |
| sponsor class | OTHER |
| enrollment | 180 |
| start date | 2026-10-26 |
| primary completion | 2030-06-01 |
| completion | 2030-06-01 |
| results posted | not reported |
Conditions
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- Acute Undifferentiated Leukemia (AUL)
- Myelodysplastic Syndrome
- Chronic Myeloid Leukemia
- Non-Hodgkin Lymphoma
Interventions
- Exercise Mobilized Prophylactic DLI
- Standard Prophylactic DLI
Countries
- United States
Intervention types: BIOLOGICAL
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.